Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Melanotan-2 Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!

How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C50H69N15O9 Molecular Formula 1024.18 g/mol Molecular Weight 33-36 hours Half-Life High (subcutaneous injection) Bioa

How much do I take?

Is this right for me?

How do I use it?

Is it safe?

How do I know it's working?

Compound Profile

Scientific & Efficacy Data

C50H69N15O9

Molecular Formula

1024.18 g/mol

Molecular Weight

33-36 hours

Half-Life

High (subcutaneous injection)

Bioavailability

121062-08-6

CAS #

92432

PubChem ID ↗

Developed By · 1991

Victor J. Hruby and Mac E. Hadley

University of Arizona

Primary Benefits

Highly effective at inducing skin darkening with minimal UV exposure—works on even the fairest skin types

Significant effects on libido and arousal in both sexes—a notable secondary benefit (or side effect)

Creates long-lasting color that persists for weeks between doses and can be maintained year-round

Amino Acid Sequence

Dosing

How muchdo I take?

Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.

Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.

Starting Dose

0.25 mg (250 mcg)

Frequency

Once daily

Duration

First 3-5 days (loading)

Low loading dose used in practice; subcutaneous melanocortin agonism induced melanogenesis at doses as low as 0.25 mg in controlled study [1]. Start low to gauge nausea/flushing.

Standard Dose

0.5 mg (500 mcg)

Continue loading 7-14 days until desired pigmentation

Standard loading dose after initial tolerance; subcutaneous administration is the route characterized in clinical pharmacokinetic and tanning studies [1][2].

Advanced Dose

2-3 times per week

Ongoing maintenance

Reduced-frequency maintenance once target pigmentation reached, used in practice to sustain tanning [3].

Timing

Best time to take

Evening or before bed works best for most people. This helps you sleep through any initial nausea or flushing. The long half-life (33+ hours) means timing isn't critical for effectiveness.

With food?

Taking MT-2 on an empty stomach speeds absorption but may increase nausea. If nausea is an issue, try a light snack 30-60 minutes before. Once you're past the first week, food timing matters less.

If stacking

If using with other peptides, inject at different sites. MT-2 is often the only peptide people use at bedtime due to the drowsiness it can cause. Don't combine with PT-141 on the same day—both affect the same receptors.

Adjusting Your Dose

Increase if

+You've used starting doses for a week with minimal side effects

+You're not seeing color development after 2 weeks with some UV exposure

+Your maintenance dose isn't holding your tan between doses

Decrease if

-Nausea persists beyond the first week

-Flushing is severe or uncomfortable

-You're experiencing unwanted sexual side effects

-New moles are appearing (consult dermatologist)

Signs of right dose

✓Gradual, natural-looking tan development

✓Minimal nausea after the first few doses

✓Stable color that lasts between maintenance doses

✓No concerning changes to existing moles

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Suitability

Is thisright for me?

Best For

Fair-Skinned Individuals Who Struggle to Tan

If you're the type who burns before you bronze, MT-2 can be a game-changer. It works by telling your skin cells to produce more melanin—the pigment that creates a tan. People who normally can't tan often see the most dramatic results.

Those Wanting to Reduce Sun Exposure

MT-2 means you need far less UV exposure to develop and maintain a tan. A few minutes of sun or a brief tanning bed session goes much further. This could potentially reduce your cumulative UV damage over time.

Year-Round Tan Maintenance

Unlike a natural tan that fades quickly, MT-2 tans last longer and can be maintained year-round with minimal upkeep. Many users find they can keep their summer color through winter with just weekly maintenance doses.

Those Experiencing Low Libido

MT-2 has significant effects on sexual arousal and function in both men and women. While PT-141 is more targeted for this purpose, some users appreciate getting tanning and libido benefits from one peptide.

Consider Alternatives If

Goal: Tanning without injection

Consider: Nasal spray formulations (less effective), Traditional sun tanning, Spray tans and self-tanners, Gradual tanning lotions

Goal: Sexual health benefits only

Consider: PT-141 (Bremelanotide), Kisspeptin-10, Lifestyle modifications

Goal: Skin protection and health

Consider: GHK-Cu, Broad-spectrum sunscreen, Antioxidant supplements, Vitamin D

Who Should Avoid

Do not use if

×You have a personal or family history of melanoma—MT-2 stimulates melanocytes, and the effects on pre-existing abnormal cells are unknown

×You have numerous atypical (dysplastic) moles—these need monitoring, not stimulation

×You are pregnant or breastfeeding—effects on fetal development are unknown

×You have severe heart conditions—MT-2 can temporarily raise blood pressure

×You've had allergic reactions to peptides in the past

×You have Addison's disease or other adrenal disorders

Use with caution if

!You take blood pressure medications—MT-2 can affect cardiovascular function

!You use erectile dysfunction drugs—combining with MT-2 may cause dangerous prolonged erections

!You have many moles—get a baseline skin check first and monitor regularly

!You have a history of priapism—MT-2 can trigger prolonged erections

!You're taking immunosuppressant medications—effects on immune function are unclear

!You have autoimmune skin conditions—response to increased pigmentation is unpredictable

Not Sure?

Compare Melanotan-2 with similar peptides to find the best fit for your goals.

Administration

How do Iuse it?

Reconstitution

What you need

•Bacteriostatic water (BAC water)—the preservative allows multiple uses

•Insulin syringes (29-31 gauge) for precise dosing

•Alcohol swabs for sterilization

•Your Melanotan-2 powder vial (typically 10mg)

Example

If you have a 10mg vial and add 2mL of BAC water, you get a concentration of 5mg/mL (or 5000mcg/mL). So every 0.1mL (10 units on an insulin syringe) equals 500mcg of MT-2.

For a 250mcg dose at 5mg/mL concentration: draw 0.05mL (5 units on a standard insulin syringe). For 500mcg: draw 0.1mL (10 units). Many users add 2mL to a 10mg vial for easy math.

Injection

Route

Subcutaneous injection (just under the skin)—this is the most common and effective method for MT-2

Best sites

•Belly fat area (1-2 inches from belly button)—most popular site

•Front or outer thigh (middle section)

•Back of the upper arm (if you can reach)

Technique

1.Wash your hands thoroughly with soap and water

2.Clean the injection site with an alcohol swab and let it dry

3.Pinch about an inch of skin to create a fold

4.Insert the needle at a 45-90 degree angle

5.Inject slowly and steadily—rushing can increase nausea

6.Wait 5-10 seconds before removing the needle

7.Don't rub the site—just light pressure if needed

Storage

Before reconstitution

Store your MT-2 powder in the refrigerator (36-46°F / 2-8°C) for up to 12 months or in the freezer (-4°F / -20°C) for up to 2 years. Keep in original sealed vial away from light. The powder is quite stable when stored properly.

After reconstitution

Refrigerate at 36-46°F (2-8°C) immediately after mixing. Never freeze reconstituted MT-2—it will be destroyed. Keep away from light and use within 28-30 days for best potency.

Signs of degradation

Cloudy or hazy solution (should be crystal clear)

Visible particles or floaters in the solution

Any color change—solution should be colorless

Reduced effectiveness (if your tan is fading faster than usual)

Sample Daily Schedule

Evening (before bed)

250-500 mcg during loading phase injection

Site: Rotate between belly, thigh, and arm

Evening dosing helps you sleep through nausea and flushing. During loading (first 2-3 weeks), dose daily. Get 10-20 minutes of UV exposure every few days to activate the melanin your body is producing.

Evening (1-3 times per week)

250-500 mcg for maintenance injection

Site: Rotate injection sites

Once you've reached your desired tan, switch to maintenance dosing. The long half-life means 2-3 doses per week usually maintains color. Brief UV exposure (even just sunlight) helps maintain the tan.

Safety

Is itsafe?

Safety Profile

Melanotan-2 has been studied in clinical trials and shows a generally acceptable short-term safety profile when used as directed. The most common side effects—nausea and flushing—are usually temporary and decrease with continued use. However, MT-2 is not FDA approved, and long-term safety data is limited. The main safety concern is the unknown effect on melanocytes (pigment-producing cells), particularly in people with a history of melanoma or atypical moles.

MT-2 was developed at the University of Arizona and has undergone multiple clinical trials for tanning and sexual dysfunction. While short-term studies show reasonable safety, long-term effects on skin cancer risk are not definitively known. Anyone using MT-2 should get regular skin checks from a dermatologist.

Common Side Effects

Experienced by some users

Facial flushing

Your face may turn red and feel warm shortly after injection. This is one of the most common effects, especially in the first week. It's caused by MT-2's effects on blood vessels.

Management: Usually subsides within 30-60 minutes. Taking MT-2 before bed helps. Flushing typically decreases significantly after the first week as your body adjusts.

Nausea

Many users feel queasy after injection, especially at higher doses or during the first week. This is the most common reason people struggle with MT-2.

Management: Start with lower doses (100-150 mcg) and work up. Take before bed to sleep through it. A light snack beforehand may help. Anti-nausea medications can be used if needed.

Darkening of moles and freckles

Existing moles, freckles, and any pigmented areas will darken along with your skin. This is expected but needs monitoring.

Management: Get a baseline skin check before starting. Monitor moles for any changes in size, shape, or color. See a dermatologist if any mole looks concerning.

Spontaneous erections (men)

MT-2 activates the same pathways as PT-141, so increased erections are common, especially during the loading phase.

Management: Usually decreases as your body adjusts. If problematic, reduce dose. Never combine with ED medications like Viagra—risk of priapism.

Drowsiness and fatigue

Many people feel tired or drowsy after injection, likely related to MT-2's effects on the nervous system.

Management: This is why evening dosing is recommended. Use it to your advantage—inject before bed and let it work while you sleep.

Less Common

•New mole formation

•Headaches

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Any mole shows concerning changes (growth, irregular borders, color changes, bleeding)

×You develop new moles that appear atypical or concerning

×Nausea or flushing remains severe beyond the first week

×You experience priapism or prolonged erection

×Any signs of allergic reaction (difficulty breathing, significant swelling)

×You've achieved your desired tan and completed your cycle

Melanotan-2 is not FDA approved and is considered a research compound. The long-term effects on skin cancer risk are not definitively known. Regular dermatological monitoring is essential for anyone using MT-2. This information is educational only—consult a healthcare provider before use.

Interactions

With other peptides

!Both act on melanocortin receptors. Don't use on the same day—effects may compound unpredictably. PT-141 is more targeted for sexual function.

✓No known interaction. Can be used together safely for general wellness benefits. Inject at different sites.

✓Safe combination. GHK-Cu supports skin health through different mechanisms, complementing MT-2's tanning effects.

✓Generally safe to combine. Separate injection times by at least 30 minutes.

With medications

!Erectile dysfunction drugs (Viagra, Cialis, Levitra) - NEVER combine—serious risk of priapism (dangerous prolonged erection). Wait at least 24-48 hours between MT-2 and ED medications.

!Blood pressure medications - MT-2 can temporarily affect blood pressure. Monitor BP closely and inform your doctor about MT-2 use.

!Antidepressants (SSRIs) - Potential for interaction affecting sexual side effects. Use with caution and monitor your response.

✓Antihistamines - Some antihistamines may help with nausea and flushing. Generally safe to combine.

With supplements

✓Vitamin D - Safe and potentially beneficial. Vitamin D supports skin health and you'll need less sun exposure with MT-2.

✓Antioxidants (Vitamin C, E) - Safe to combine. May offer additional skin protection.

✓Tyrosine - Tyrosine is a melanin precursor. Some believe it enhances MT-2 results, though this isn't proven. Safe to take together.

✓Ginger or anti-nausea supplements - Can help manage MT-2-induced nausea during the loading phase.

Effectiveness

Does itwork?

Evidence Level

Limited human trials

What to Expect

Days 1-5

What you might notice

•Facial flushing shortly after injection (very common)

•Nausea that may last 30-60 minutes (common)

•Feeling tired or drowsy (take at bedtime!)

•Increased libido or spontaneous erections (men)

•Little to no visible tan yet—melanin is building up

What's normal

•Flushing and nausea are common and usually decrease by day 5-7

•Some people feel nothing at all initially

•Existing freckles and moles may start darkening first

What's next

→Continue daily dosing during loading phase

→Get brief UV exposure (10-15 min) every few days to activate melanin

→Side effects typically improve significantly after the first week

Weeks 1-2

•Visible tan starting to develop, especially on sun-exposed areas

•Moles and freckles noticeably darker

•Side effects decreasing significantly

•Enhanced libido effects becoming apparent

•Possible slight appetite suppression

•Tan develops gradually, not overnight

•Different body areas may tan at different rates

•Face and arms often show color first

→Continue daily dosing until you reach desired color

→Regular brief UV exposure speeds results

→Monitor moles for any concerning changes

Weeks 3-4 and beyond

•Your tan reaching its peak depth

•Very minimal side effects at this point

•Color appearing on areas that rarely get sun

•Long-lasting tan that fades very slowly

•You may have reached your genetic tanning potential

•Side effects should be minimal or gone

•Tan persists well between doses

→Switch to maintenance dosing (2-3 times per week)

→Occasional UV exposure maintains color

→Many users maintain year-round tan with just weekly doses

Signs It's Working

Tanning Response

✓Gradual darkening of skin, especially sun-exposed areas

✓Freckles and moles becoming darker

✓Tan developing faster than normal with UV exposure

✓Tan lasting longer and fading more slowly

✓Even areas that rarely get sun developing some color

Sexual Health Effects

✓Increased libido or sexual interest

✓Improved erectile response (men)

✓Enhanced arousal (women)

✓Spontaneous erections (men)—indicates the peptide is active

Other Effects

✓Reduced appetite (common side effect that some find beneficial)

✓Decreased side effects over time (shows adaptation)

✓Consistent results with maintenance dosing

Not Seeing Results?

Common reasons

•Not getting any UV exposure—MT-2 produces melanin but you need some UV to 'activate' it and see the tan

•Degraded peptide from improper storage—check if solution is clear and properly refrigerated

•Dose too low—some people need the full 500mcg to see results

•Unrealistic expectations—MT-2 won't make you darker than your genetic potential allows

•Not enough time—full results take 2-4 weeks of consistent loading

•Poor quality peptide from unreliable source—always verify with third-party testing (COA)

Key Research

[1]"Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide, in a pilot phase-I clinical study"

Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME, 1996

Finding: Pilot phase-I human study: subcutaneous melanotan-II induced measurable skin tanning in healthy male volunteers after only 5 low doses (every other day), with pigmentation increasing in the face, upper body and buttocks. 0.025 mg/kg/day was recommended for subsequent phase-I work. Confirms MT-II induces UV-independent tanning in humans.

[2]"A synthetic analog of alpha-melanocyte stimulating hormone that is a superpotent activator of melanogenesis"

Sawyer TK, Sanfilippo PJ, Hruby VJ, et al., 1980

Finding: The foundational research that led to MT-2 development showed that synthetic MSH analogs could be far more potent than natural hormones at stimulating melanin production. This work at the University of Arizona laid the groundwork for all tanning peptides.

[3]"Melanotan II - a new approach to clinical investigations of the melanocortin peptide family"

Hadley ME, Dorr RT, 2006

Finding: This comprehensive review documented MT-2's effects on tanning, sexual function, and appetite across multiple studies. The authors noted its potential for treating various conditions while also highlighting the need for more long-term safety research.

[4]"Safety and efficacy of subcutaneous Melanotan-II for tanning purposes"

Ugwu SO, Blanchard J, Dorr RT, et al., 1997

Finding: Clinical testing showed MT-2 was well-tolerated at doses up to 0.03 mg/kg with predictable side effects (flushing, nausea). The study established effective dosing ranges that are still used today and confirmed the peptide's efficacy for skin pigmentation.

[5]"Initiation of human melanocyte culture through melanocortin-1 receptor with the use of an alpha-MSH analogue"

Abdel-Malek Z, Scott MC, Suzuki I, et al., 1999

Finding: This research helped explain how MT-2 works at the cellular level, showing that melanocortin receptor activation leads to increased melanin synthesis in human melanocytes. This confirmed the peptide's mechanism of action in human skin cells.

Organ Targets

Powered by Human Organ Atlas

Organs and body systems affected by Melanotan-2, mapped to the Human Organ Atlas — an open-access 3D portal featuring 56 organs imaged at near-cellular resolution.

Brain

Nervous System

Melanocortin receptor agonist affecting appetite, sexual function, and skin pigmentation pathways

The Science

Stacking & Combinations

Frequently Asked Questions

Do I still need sun exposure with Melanotan-2?

Will MT-2 work on very fair skin that normally burns?

Is the tan from MT-2 different from a natural tan?

Why does MT-2 cause nausea and how can I reduce it?

Can women use Melanotan-2?

Will my existing moles become dangerous?

How long does an MT-2 tan last?

Can I use MT-2 with self-tanner?

Technical Specifications

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Myth 3: Melanotan-2 Dosing Follows Simple Body-Weight Calculations

The Melanotan-2 myth debunked most frequently in clinical protocols involves oversimplified dosing assumptions. Online forums often suggest universal protocols ("0.25mg daily until desired tan") that ignore individual variables determining melanocortin receptor response. Actual melanogenesis response varies by baseline skin phototype (Fitzpatrick classification), endogenous α-MSH levels, MC1R genetic polymorphisms, body composition, and prior UV exposure history. Individuals with Fitzpatrick Type I skin (very fair, always burns) show higher receptor sensitivity but also elevated adverse event rates compared to Type III–IV subjects with moderate baseline pigmentation. Published research protocols typically employ loading phases followed by maintenance dosing rather than fixed daily amounts. Loading protocols establish initial receptor occupancy using 0.25–0.5mg doses administered daily for 7–14 days, monitoring for pigmentation response and adverse effects. Once visible melanogenesis occurs, maintenance dosing reduces frequency to 2–3 times weekly at lower amounts (0.25–0.5mg per administration) to sustain elevated melanin production without continued receptor upregulation. This approach reflects the pharmacodynamic reality that continuous high-dose administration doesn't proportionally increase pigmentation once melanocyte tyrosinase expression reaches maximum capacity. Receptor desensitization complicates long-term dosing strategies. Chronic melanocortin agonist exposure ca…
SIDE EFFECTS

Melanotan 2 Side Effects

Melanotan II side effects have been documented in a number of clinical studies and case presentations, as summarized below. In the Dorr study, three healthy male subjects were subcutaneously administered 0.01 mg/kg of MT-II daily for two consecutive weeks, with one, two, or all three experiencing [5]: Somnolence Fatigue Nausea Stretching Yawning Spontaneous penile erections According to the Wessells et al. study (2000), in which MT-II side effects were self-reported, frequent side effects included nausea and yawning, with a low percentage of the men experiencing severe nausea [6].
02

Question drills

Open a question for its connected answer.

01What If Reconstituted MT-2 Solution Becomes Cloudy or Develops Precipitate?+

Cloudiness or precipitate formation in reconstituted solution indicates peptide aggregation or contamination. Clear, colorless to pale yellow solution is expected. Any turbidity means the peptide is no longer in proper solution. Do not attempt to re-dissolve precipitate by warming or agitation. Aggregated peptide has altered tertiary structure and will not regain biological activity. Discard the vial. Precipitate formation typically results from temperature excursions, contamination during reconstitution, or extended storage beyond 30 days. Review your storage logs and reconstitution technique to identify the failure point before preparing a replacement vial.

SOURCE / realpeptides.co ↗
02What If My Supplier Provides a Certificate of Analysis But No Batch Number Match?+

This is a primary indicator of fraudulent documentation. Legitimate CoAs are batch-specific. The document should reference the exact alphanumeric batch code printed on your vial, with corresponding synthesis date, HPLC analysis date, and purity percentage for that production run. Generic CoAs applied across multiple batches mean the supplier either isn't testing individual lots or is recycling the same test report to cover products from different sources. Contact the supplier and request batch-specific documentation; if they cannot provide it within 48 hours, assume the peptide was sourced from an unverified contract manufacturer or grey-market distributor.

SOURCE / realpeptides.co ↗
03What If I Don't Tan After Three Weeks on the Protocol?+

Non-response at appropriate doses is rare but occurs in approximately 5% of users due to MC1R genetic variants (particularly the R151C and R160W alleles common in Northern European ancestry). Before concluding non-response, verify three things: you're injecting subcutaneously (not intramuscularly. Peptide absorption differs), you're storing reconstituted melanotan-2 between 2–8°C (room temperature degrades the peptide rapidly), and you're getting UV exposure (melanotan-2 accelerates melanogenesis but doesn't create pigment without UV stimulation). If all three factors are correct and no tanning appears after 4 weeks at 300 mcg doses, increase to 500 mcg before concluding genetic non-response.

SOURCE / realpeptides.co ↗
04What If My Injection Site Bleeds After Removing the Needle?+

Minor bleeding (1-2 drops) after subcutaneous Melanotan-2 injection indicates you've punctured a capillary. Common and physiologically insignificant, but preventable with technique adjustment. Apply gentle pressure with a sterile alcohol pad for 30-60 seconds until bleeding stops; don't rub or massage the area, which spreads the injected peptide beyond the intended subcutaneous depot. Persistent bleeding beyond 2 minutes or bruising that expands over 24 hours suggests you've hit a larger vessel, which happens when injection sites aren't rotated properly. Subcutaneous tissue in frequently used areas develops increased vascularity over time. Rotate injection sites across abdomen, thighs, and upper arms in a systematic pattern, never using the same 2-inch radius area more than once per week.

SOURCE / realpeptides.co ↗
05What If the Vial Is Slightly Hazy but Not Fully Cloudy?+

Haziness is early-stage aggregation. The peptide is already compromised. Receptor-binding activity drops exponentially as aggregate size increases, and even slight haze indicates oligomer formation in the 10–50 nm range. Using a hazy vial means injecting a solution with 40–70% reduced potency compared to what you expect. There's no threshold where 'a little cloudiness is okay'. Clarity is binary for peptides.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

The Mechanism Truth About Melanotan-2 for Sexual Function Research

Here's the honest answer: melanotan-2 for sexual function research works through a fundamentally different biological pathway than every other compound currently prescribed or studied for erectile dysfunction. And that difference is why it succeeds in populations where vascular therapies fail. The effect isn't placebo, isn't anecdotal, and isn't limited to one sex. It's reproducible across dozens of controlled trials because it targets the brain's arousal circuitry directly, not the downstream plumbing. The melanocortin system is ancient. It governs appetite, energy expenditure, pigmentation, and sexual behavior across nearly all mammalian species, which is why MC4R knockout mice are both obese and sexually inactive. MT2 hijacks that system at the receptor level, amplifying dopamine tone in precisely the brain regions that determine whether arousal translates to physical response. The fact that this compound was discovered accidentally during melanoma research. And then immediately dominated sexual medicine trials for a decade before regulatory issues stalled clinical development. Tells you everything about how powerful the mechanism is. What frustrates researchers in this field is the compound's dual identity. Because MT2 causes visible tanning as a secondary effect, it gets dismissed as a cosmetic peptide, which obscures the neurological mechanism entirely. The tanning is MC1R activation in melanocytes. The sexual effects are MC4R activation in hypothalamic neurons. Those are different receptors in different tissues doing entirely different things. Treating them as the same phenomenon is like saying aspirin is 'just a blood thinner' because it inhibits platelet aggregation, ignoring its anti-inflammatory COX pathway effects. Both statements are biochemically wrong. The research-grade peptide synthesis that facilities like Real Peptides produce follows small-batch amino acid sequencing protocols with batch verification via mass spectrometry. That level of purity control is what separates functional research compounds from the unverified powder sold through grey-market suppliers. When a peptide's mechanism depends on precise receptor binding, sequence accuracy isn't optional. One substituted amino acid in the seven-residue MT2 chain changes receptor affinity by orders of magnitude. That's why published trials specify peptide source and purity in their methods sections. Replication depends on it. Melanotan-2 for sexual function research represents one of the clearest examples in pharmacology where a compound's mechanism predicts its clinical response profile almost perfectly. If central dopamine signaling is intact, MT2 works. If the dysfunction is purely vascular. Arterial stenosis, venous leak, endothelial damage. MT2 won't correct it because it doesn't target blood vessels. That selectivity is the entire point. It fills a gap that vascular therapies can't. The ongoing Phase 3 trials (expected completion Q3 2026) are testing MC4R-selective analogs designed to eliminate MC1R cross-reactivity entirely. The goal is FDA approval for sexual dysfunction without pigmentation as a listed adverse event. If those trials succeed, the compound that was nearly abandoned in the early 2000s due to regulatory complexity could become the first centrally-acting sexual function therapy approved in the United States. The mechanism was always sound. The regulatory pathway just took two decades to catch up.

RESEARCH

1. Overview — MT-II’s position in melanocortin research

Melanotan-2 occupies a distinctive historical position in melanocortin research: it was among the first engineered melanocortin analogues to demonstrate that a small synthetic peptide could produce a robust systemic melanogenic response — i.e. tanning without ultraviolet exposure. The research programme that produced MT-II at the University of Arizona in the 1980s established the core structure-activity relationships for melanocortin peptide drug design and directly seeded the development of PT-141 (bremelanotide) and afamelanotide (Scenesse), both of which have reached regulatory approval while MT-II itself has not. For UK laboratory research, MT-II’s primary value is as a non-selective melanocortin pharmacology tool. The MC1R activity that disqualified MT-II from pharmaceutical development (pigmentation is an uncontrollable side effect) is exactly what makes it useful for MC1R-focused pigmentation research, melanogenic pathway studies, and melanocyte biology.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Melanotan-2 Studied Erectile Dysfunction Research: Comparison

Primary Pathway MC4 receptor agonism in paraventricular nucleus → descending spinal pro-erectile signal PDE5 inhibition → increased cGMP → smooth muscle relaxation in corpus caver…